NCT06238921 2025-12-05Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain MetastasesH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Recruiting31 enrolled
NCT01217411 2024-11-19RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerNational Cancer Institute (NCI)Phase 1/2 Terminated5 enrolled 6 charts